| abstract |
The present disclosure relates to chemical entities useful as inhibitors of ubiquitin-specific peptidase 30 (USP30), pharmaceutical compositions comprising the chemical entities, and methods of using the chemical entities. The chemical entities disclosed herein are useful in the treatment of diseases, disorders or conditions involving mitochondrial dysfunction, including neurodegenerative diseases, motor neuron diseases, metabolic disorders and cancer, among others. |